CULLINAN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.44 USD | +2.05% |
|
+0.06% | +71.15% |
| 02/06 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
| 01/06 | Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 19.47 | 29.35 | 28.35 |
| Spread/Res. | -10.43% | -40.58% | -38.48% |
| Spread/Supp. | +6.21% | +11.58% | +11.37% |
| Support | 16.42 | 15.63 | 15.66 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CGEM Stock
- Charts Cullinan Therapeutics, Inc.
